Taking a particular type of medication to treat enlarged prostate is associated with a reduced risk of developing Parkinson's disease, according to a large observational study by researchers at the University of Iowa, and colleagues in Denmark and China. The findings, published in JAMA Neurology, suggest that terazosin, and similar medications, might have potential to prevent or delay the development of Parkinson's disease.
from Latest Science News -- ScienceDaily https://ift.tt/2YA6x9l
via IFTTT
Monday, February 1, 2021
Prostate drug associated with lower risk of Parkinson's disease
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment